Japan’s SAKIGAKE designation may help accelerate development and review of the embryonic stem cell-derived therapy.
Read More
The Phase II trial showed significant motor function improvements and safety for an allogeneic stem cell therapy in Parkinson’s disease.
Read More
A pioneering UC Irvine study will assess the safety and potential benefits of embryo-derived neural stem cell therapy for Huntington’s disease.
Read More
Nature Cell’s new facility will focus on stem cell therapeutics, research, and manufacturing, supported by the Maryland Stem Cell Research Fund.
Read More
The new funding round will help advance their iPSC-derived dopaminergic neuronal precursor cell trials, manufacturing, and continued development of other iPSC therapies.
Read More
NurExone's SCI candidate showed 100% gait recovery in rat models, and they're gearing up for human trials hopefully in 2026. Enjoy the interview!
Read More
Designed for 2D and 3D cultures, this platform aims to offer greater consistency and scalability in neuronal research.
Read More
Researchers have seen good success in animal studies, and are advancing to the first clinical trials in humans. What a time to be alive.
Read More
Indiana University’s new MAP-AD center will use stem-cell-derived brain models and AI to advance Alzheimer’s research and drug development.
Read More